Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.95
Delayed Data
As of Oct 18
 -0.01 / -0.51%
Today’s Change
1.56
Today|||52-Week Range
10.90
-63.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line-2.9M-2.8M-1.6M-2.2M
 
 
 
 
 
Depreciation34.0K24.0K9.0K8.0K
 
 
 
 
 
Total Other Cash Flow194.0K156.0K69.0K66.0K
 
 
 
 
 
Funds From Operations-2.7M-2.7M-1.5M-2.1M
 
 
 
 
 
Funds From/For Other Operating Expenses235.0K284.0K2.3M-1.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-3.0M-2.9M-3.8M-201.0K
 
 
 
 
 
 
InvestingCapital Expenditures0.00-3.0K-2.0K0.00
 
 
 
Fixed Asset Disposal0.0012.0K----
 
 
Net Cash Flow Investing0.009.0K-2.0K0.00
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale5.1M1.6M86.0K977.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total-50.0K-50.0K-50.0K-51.0K
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing5.0M1.5M36.0K926.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash14.0K-78.0K-15.0K137.0K
 
 
 
 
 
 
Net Change In Cash2.1M-1.4M-3.8M725.0K